SkinBioTherapeutics (SBTX) Competitors GBX 17 -0.75 (-4.23%) (As of 08:24 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitors SBTX vs. HVO, CIR, SCLP, TILS, VSN, FUM, MPH, ORPH, REDX, and ETXShould you be buying SkinBioTherapeutics stock or one of its competitors? The main competitors of SkinBioTherapeutics include hVIVO (HVO), Circassia Group (CIR), Scancell (SCLP), Tiziana Life Sciences (TILS), Verseon (VSN), Futura Medical (FUM), Mereo BioPharma Group plc (MPH.L) (MPH), Open Orphan (ORPH), Redx Pharma (REDX), and e-therapeutics (ETX). These companies are all part of the "biotechnology" industry. SkinBioTherapeutics vs. hVIVO Circassia Group Scancell Tiziana Life Sciences Verseon Futura Medical Mereo BioPharma Group plc (MPH.L) Open Orphan Redx Pharma e-therapeutics hVIVO (LON:HVO) and SkinBioTherapeutics (LON:SBTX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, earnings, profitability, media sentiment, valuation, risk and community ranking. Which has more risk & volatility, HVO or SBTX? hVIVO has a beta of 0.97, indicating that its stock price is 3% less volatile than the S&P 500. Comparatively, SkinBioTherapeutics has a beta of 2.01, indicating that its stock price is 101% more volatile than the S&P 500. Does the MarketBeat Community favor HVO or SBTX? hVIVO received 76 more outperform votes than SkinBioTherapeutics when rated by MarketBeat users. Likewise, 69.89% of users gave hVIVO an outperform vote while only 60.26% of users gave SkinBioTherapeutics an outperform vote. CompanyUnderperformOutperformhVIVOOutperform Votes12369.89% Underperform Votes5330.11% SkinBioTherapeuticsOutperform Votes4760.26% Underperform Votes3139.74% Which has better valuation & earnings, HVO or SBTX? hVIVO has higher revenue and earnings than SkinBioTherapeutics. SkinBioTherapeutics is trading at a lower price-to-earnings ratio than hVIVO, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatiohVIVO£67.21M2.14£17.45M£0.03704.17SkinBioTherapeutics£21.95K1,751.12-£2.88M-£0.02-850.00 Does the media prefer HVO or SBTX? In the previous week, SkinBioTherapeutics had 2 more articles in the media than hVIVO. MarketBeat recorded 2 mentions for SkinBioTherapeutics and 0 mentions for hVIVO. SkinBioTherapeutics' average media sentiment score of 1.06 beat hVIVO's score of 0.00 indicating that SkinBioTherapeutics is being referred to more favorably in the news media. Company Overall Sentiment hVIVO Neutral SkinBioTherapeutics Positive Is HVO or SBTX more profitable? hVIVO has a net margin of 25.96% compared to SkinBioTherapeutics' net margin of 0.00%. hVIVO's return on equity of 58.04% beat SkinBioTherapeutics' return on equity.Company Net Margins Return on Equity Return on Assets hVIVO25.96% 58.04% 11.97% SkinBioTherapeutics N/A -118.63%-61.18% Do insiders & institutionals hold more shares of HVO or SBTX? 34.9% of hVIVO shares are owned by institutional investors. Comparatively, 16.6% of SkinBioTherapeutics shares are owned by institutional investors. 14.0% of hVIVO shares are owned by company insiders. Comparatively, 20.4% of SkinBioTherapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. SummaryhVIVO beats SkinBioTherapeutics on 10 of the 15 factors compared between the two stocks. Ad Investors AlleyStrange: Why is Amazon suddenly yielding 39.70%?Something big is happening with Amazon stock… While most investors collect ZERO dividends from Amazon… A small group just discovered a "backdoor" way to collect yields up to 39.70%!Click here to see this breakthrough before everyone else → Get SkinBioTherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SBTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SBTX vs. The Competition Export to ExcelMetricSkinBioTherapeuticsBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£38.44M£147.39M£5.27B£1.42BDividend YieldN/A3.55%5.71%11.72%P/E Ratio-850.00329.4286.231,567.01Price / Sales1,751.1216,638.911,310.46363,151.14Price / Cash9.0011.7841.3232.92Price / Book8.507.554.782.88Net Income-£2.88M-£12.81M£119.62M£152.61M7 Day Performance7.09%1.49%3.22%9.14%1 Month Performance11.11%9.98%2.62%8.96%1 Year Performance3.03%24.91%32.46%95.82% SkinBioTherapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SBTXSkinBioTherapeuticsN/AGBX 17-4.2%N/A+8.3%£38.44M£21,949.00-850.0011News CoveragePositive NewsHVOhVIVON/AGBX 21.40-1.6%N/A+4.4%£145.60M£67.21M708.90N/APositive NewsCIRCircassia GroupN/AGBX 34-6.8%N/A+0.0%£142.66M£27.90M3,400.00111Gap DownSCLPScancellN/AGBX 13-1.9%N/A+10.6%£120.85M£5.27M-1,300.0051News CoverageTILSTiziana Life SciencesN/AGBX 58.50+8.3%N/A+0.0%£113.85M£-3,595,000.00-3.5911News CoverageVSNVerseonN/AGBX 74+2.1%N/A+0.0%£112.24MN/A-5.17N/AGap UpFUMFutura MedicalN/AN/AN/A+9.0%£101.30M£8.40M-3,320.0012MPHMereo BioPharma Group plc (MPH.L)N/AN/AN/A+0.0%£89.76MN/A-0.2150Gap DownORPHOpen OrphanN/AGBX 10+5.3%N/A+0.0%£67.09M£34.71M-25.30179REDXRedx PharmaN/AN/AN/A-37.5%£58.35M£4.20M-150.00101Gap UpHigh Trading VolumeETXe-therapeuticsN/AN/AN/A-0.7%£52.59M£295,000.00-450.0035High Trading Volume Related Companies and Tools Related Companies hVIVO Alternatives Circassia Group Alternatives Scancell Alternatives Tiziana Life Sciences Alternatives Verseon Alternatives Futura Medical Alternatives Mereo BioPharma Group plc (MPH.L) Alternatives Open Orphan Alternatives Redx Pharma Alternatives e-therapeutics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:SBTX) was last updated on 12/5/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredWaveBot: The Automated Trading Tool for This Bull MarketThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredEven Trump can’t stop what’s coming.No matter who sits in the White House over the next four years, a series of events has been triggered that cou...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SkinBioTherapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share SkinBioTherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
